1. PD-0908 PSA Progression and survival in mCRPC patients treated with abiraterone or enzalutamide. (August 2021) Authors: Lopez Campos, F.; Lorente, D.; Llacer, C.; érez, P.; Gómez-Iturriaga, A.; Henriquez-López, I.; Peleteiro, P.; Ramirez-Backhaus, M.; Navarro-Castellón, J.; Lozano, R.; Romero, N.; Gajate, P.; Ana, C.; Gómez, J.; Álvarez, S.; Molina-Cerrillo, J.; Pelari, L.; Hernández-Corrales, A.; Morillo, V.; Gar... Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗